机译:The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA;
MedStar Washington Hosp Ctr, Washington Canc Inst, Washington, DC USA;
NCI, Womens Malignancies Branch, Ctr Canc Res, NIH, Bldg 10,Room 4B54, Bethesda, MD 20892 USASAIC Frederick, Ctr Canc Res Bioinformat Core, Adv Biomed Comp Ctr, Frederick, MD USAUniv Missouri, Sinclair Sch Nursing, Columbia, MO USANCI, Biostat & Data Management Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA;
TRAIL receptor agonists; Drozitumab; Triple-negative breast cancer; Vimentin; Axl;